日祥展示口樂安®於Cell Therapy World Asia 2020
日祥受邀在2020年10月21日至22日在韓國主辦的Cell Therapy World Asia 2020線上會議給予演講，主題為“口腔癌早期檢測專家”。演講內容涵蓋Oral-M®檢測技術以及口腔癌檢測的臨床應用。
本次盛會匯聚了亞太、歐洲和美國的細胞與基因治療領域各方專家和領袖。可增進相關產業之間的專業討論、案例研究以及交流機會。
更多資訊請瀏覽: https://tw.epigenebio.com/
|
|
iStat Biomedical showcases Oral-M® at Cell Therapy World Asia 2020 |
iStat Biomedical Co., Ltd. is invited to present a topic “Early Detection Expert on Oral Cancer” at the Cell Therapy World Asia 2020, an event held as online conference in Korea from October 21st to 22nd, 2020. The topic covers the technology and clinical application aspect of Oral-M® in detecting oral cancer.
This is event gathers world-class experts and cell & gene therapy industry leaders across Asia-Pacific, Europe and the United States. Participants are exposed to professional discussions and case studies on the booming opportunities of the industry in Asia and beyond, particularly good networking opportunities.
For more information, please visit: https://tw.epigenebio.com/
About iStat Biomedical
iStat Biomedical is a Taiwan-based biotechnology company specialized in the development and manufacturing of gene methylation assay IVD products for the early detection of cancers. iStat Biomedical develops innovative products that are primarily used in the clinical laboratories, and provides physicians with alternative solutions for clinical managements. iStat Biomedical also provides services for gene methylation detection and IVD contract manufacturing.
iStat Biomedical Co., Ltd contact:
+886-2-26963518
日祥受邀在2020年10月21日至22日在韓國主辦的Cell Therapy World Asia 2020線上會議給予演講，主題為“口腔癌早期檢測專家”。演講內容涵蓋Oral-M®檢測技術以及口腔癌檢測的臨床應用。
本次盛會匯聚了亞太、歐洲和美國的細胞與基因治療領域各方專家和領袖。可增進相關產業之間的專業討論、案例研究以及交流機會。
更多資訊請瀏覽: https://tw.epigenebio.com/
|
|
iStat Biomedical showcases Oral-M® at Cell Therapy World Asia 2020 |
iStat Biomedical Co., Ltd. is invited to present a topic “Early Detection Expert on Oral Cancer” at the Cell Therapy World Asia 2020, an event held as online conference in Korea from October 21st to 22nd, 2020. The topic covers the technology and clinical application aspect of Oral-M® in detecting oral cancer.
This is event gathers world-class experts and cell & gene therapy industry leaders across Asia-Pacific, Europe and the United States. Participants are exposed to professional discussions and case studies on the booming opportunities of the industry in Asia and beyond, particularly good networking opportunities.
For more information, please visit: https://tw.epigenebio.com/
About iStat Biomedical
iStat Biomedical is a Taiwan-based biotechnology company specialized in the development and manufacturing of gene methylation assay IVD products for the early detection of cancers. iStat Biomedical develops innovative products that are primarily used in the clinical laboratories, and provides physicians with alternative solutions for clinical managements. iStat Biomedical also provides services for gene methylation detection and IVD contract manufacturing.
iStat Biomedical Co., Ltd contact:
+886-2-26963518